Does metformin do more benefit or harm in chronic kidney disease patients?

Kidney Int. 2020 Nov;98(5):1098-1101. doi: 10.1016/j.kint.2020.04.059.

Authors

Marc E De Broe¹, François Jouret²

Affiliations

¹ Laboratory Physiopathology, University of Antwerp, Liège, Belgium. Electronic address: marc.debroe@uantwerpen.be.
² Research Department of Pathophysiology, Department Nephrology, University Hospital of Liège, Antwerpen, Belgium. Electronic address: francois.jouret@chuliege.be.

PMID: 33126974
DOI: 10.1016/j.kint.2020.04.059

No abstract available

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Humans
Hypoglycemic Agents / adverse effects
Metformin* / adverse effects
Renal Insufficiency, Chronic* / diagnosis

Substances

Hypoglycemic Agents
Metformin